CYTRX CORP
S-3, EX-23.2, 2000-09-12
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: CYTRX CORP, S-3, EX-5, 2000-09-12
Next: RENTRAK CORP, DEFA14A, 2000-09-12



<PAGE>

                                                                    EXHIBIT 23.2

                        CONSENT OF INDEPENDENT AUDITORS

We consent to the reference to our firm under the caption "Experts" in the
Registration Statement on Form S-3 and related Prospectus of CytRx Corporation
for the registration of 850,000 shares of its common stock and to the
incorporation by reference therein of our report dated March 15, 2000, except
for Note 13, paragraphs 10 and 11, as to which the date is June 15, 2000 with
respect to the restated consolidated financial statements and schedule of CytRx
Corporation included in its Current Report on Form 8-K dated June 18, 2000,
filed with the Securities and Exchange Commission.

                                                /s/ ERNST & YOUNG LLP

Atlanta, Georgia
September 5, 2000



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission